Literature DB >> 26931318

Cancer biology: TGFβ and EMT as double agents.

Paulina Strzyz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26931318     DOI： 10.1038/nrm.2016.26

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN： 1471-0072            Impact factor:   94.444


× No keyword cloud information.
  1 in total

1.  TGF-β Tumor Suppression through a Lethal EMT.

Authors:  Charles J David; Yun-Han Huang; Mo Chen; Jie Su; Yilong Zou; Nabeel Bardeesy; Christine A Iacobuzio-Donahue; Joan Massagué
Journal:  Cell       Date:  2016-02-18       Impact factor: 41.582
  1 in total
  4 in total

Review 1.  Naturally occurring compounds acting as potent anti-metastatic agents and their suppressing effects on Hedgehog and WNT/β-catenin signalling pathways.

Authors:  L Farahmand; B Darvishi; K Majidzadeh-A; A Madjid Ansari
Journal:  Cell Prolif       Date:  2016-09-27       Impact factor: 6.831

2.  Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology.

Authors:  N Jumper; T Hodgkinson; R Paus; A Bayat
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

3.  Downregulation of FOXP2 promotes breast cancer migration and invasion through TGFβ/SMAD signaling pathway.

Authors:  Meng-Ting Chen; He-Fen Sun; Liang-Dong Li; Yang Zhao; Li-Peng Yang; Shui-Ping Gao; Wei Jin
Journal:  Oncol Lett       Date:  2018-03-30       Impact factor: 2.967

4.  DCST1-AS1 Promotes TGF-β-Induced Epithelial-Mesenchymal Transition and Enhances Chemoresistance in Triple-Negative Breast Cancer Cells via ANXA1.

Authors:  Li Tang; Yuli Chen; Huanhuan Chen; Pan Jiang; Linping Yan; Dongping Mo; Xun Tang; Feng Yan
Journal:  Front Oncol       Date:  2020-03-12       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.